Stay updated with breaking news from Joant Merrill. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tapering is best reserved for those in complete remission with stable disease for at least 6 months, although many individual patient characteristics must be taken into account, experts say.
For patients with systemic lupus erythematosus (SLE), iberdomide at a higher dose is superior to placebo for the rate of response indicating reduction in disease activity.
Mid-stage study offers hope but also reason for caution